Philippines - English - FDA (Food And Drug Administration)

fresenius kabi philippines, inc.; distributor: fresenius kabi philippines, inc. - sucroferric oxyhydroxide - chewable tablet - 2.5 g (equivalent to 500 mg iron)

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kissei pharmaceutical co., ltd. - sucroferric oxyhydroxide - brown tablet, outside diameter: 16.5 mm, internal diameter: 5.5 mm, thickness: about 5.2 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kissei pharmaceutical co., ltd. - sucroferric oxyhydroxide - brown tablet, outside diameter: 20.5 mm, internal diameter: 6.0 mm, thickness: about 6.4 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kissei pharmaceutical co., ltd. - sucroferric oxyhydroxide - brown granules

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kissei pharmaceutical co., ltd. - sucroferric oxyhydroxide - brown granules

European Union - English - EMA (European Medicines Agency)

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemic preparations - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; hypromellose; silicon dioxide; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 300 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; microcrystalline cellulose; hypromellose; silicon dioxide; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 450 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; hypromellose; magnesium stearate; silicon dioxide; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.